ADELANTE Study to Improve HIV Care Engagement and Viral Suppression in Latino Adults

What this Trial Is About

This research aims to evaluate the effectiveness of ADELANTE, a behavioral intervention, in helping Latino adults with HIV who have not achieved viral suppression. The study will compare ADELANTE with an enhanced care condition ECC to see which better supports viral suppression and reduces emergency room visits and hospitalizations over 12 months. It focuses on participants who have been on HIV treatment for at least three months but still have detectable viral loads. Participants will be randomly assigned to either the ADELANTE group, which receives five individualized problem-solving sessions delivered by bilingual community health workers over six months, or the ECC group, which receives five reminder phone calls without additional intervention. The ADELANTE program uses motivational interviewing, a drama-based HIV telenovela, and links participants to needed services to improve treatment adherence and self-management. Participants will be assessed at the start, then at 3, 6, and 12 months after randomization. These assessments will measure viral suppression, emergency department visits, hospitalizations, and retention in care. Study staff who do not know participants group assignments will conduct evaluations. Participants will be compensated for each completed assessment, and their progress will be monitored throughout the yearlong study.

ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV